
Selvita S.A. Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Selvita S.A.
Access all reports
Selvita S.A. is active in the pharmaceutical and biotechnology sectors. The company specializes in providing integrated services that encompass a wide range of solutions to support drug discovery, regulatory studies, and research and development. Selvita offers comprehensive drug discovery support from the initial stages of target validation through to the preclinical research phase, including the development and validation of drug testing and bioanalytical methods. The organization works closely with various research institutes and universities primarily in Europe and the United States. Founded in 2007, Selvita employs a large team of professionals, including a significant proportion with PhD qualifications. The company is headquartered in Krakow, Poland, and its shares are listed on the Warsaw Stock Exchange.
Latest articles
)
Upcoming IPOs to Watch in 2025
Potential IPOs in 2025 include prominent names like Shein, Databricks, Klarna, eToro, and Figma, to name a few. Let's take a closer look.
23 May 2025
)
Figma: Collaborative Design Tool Ready for IPO
Figma, the popular design platform, is preparing for a potential IPO in 2025 as it continues to reshape the future of collaborative design.
22 May 2025
)
Companies That Had Their IPO in 2024: Momentum Increasing
2024 marked a steady year for IPOs, driven by strong markets, AI momentum, and high-profile listings across industries and regions.
22 May 2025
Ticker symbol
SLV
Country
🇵🇱 Poland